Attorney General Raoul Urges U.S. Supreme Court To Reverse Mifepristone Restrictions
CHICAGO - Attorney General Kwame Raoul today, with 23 attorneys general, filed a brief in the U.S. Supreme Court to protect access to medication abortion nationwide. Raoul and the coalition filed the amicus brief supporting efforts undertaken by the U.S. Food and Drug and Administration (FDA) and Danco Laboratories LLC to reverse a ruling by the U.S. Court of Appeals for the 5th Circuit that reinstated certain restrictions on the medication known as mifepristone, after the FDA had determined those restrictions were medically unnecessary. Raoul and the coalition argue that the 5th Circuit’s ruling reinstating medically-unnecessary restrictions on the medication has dangerous consequences for reproductive health care outcomes, particularly for low-income and underserved communities. “For nearly 25 years, mifepristone has been safely utilized by millions of American patients, and restricting mifepristone only serves to block access to the most commonly used methods of abortion,&rdquo
stLouIST